Literature DB >> 29654899

"Trans-nonachlor increases extracellular free fatty acid accumulation and de novo lipogenesis to produce hepatic steatosis in McArdle-RH7777 cells".

George Eli Howell1, Erin McDevitt2, Lucie Henein2, Charlee Mulligan2, Darian Young2.   

Abstract

Recent studies suggest there may be an environmental exposure component to the development and progression of non-alcoholic fatty liver disease (NAFLD) involving the organochlorine (OC) pesticides or their metabolites. However, the roles of OC compounds in the development of NAFLD has not been fully elucidated. Therefore, the current study was designed to determine if exposure to trans-nonachlor, a prevalent OC compound, could promote hepatocyte lipid accumulation and determine potential pro-steatotic mechanisms. McArdle-RH7777 (McA) hepatoma cells were incubated with trans-nonachlor for 24 h then neutral lipid accumulation was determined by Oil Red O staining. Exposure to trans-nonachlor produced a concentration dependent increase in neutral lipid accumulation. Trans-nonachlor also increased extracellular free fatty acid-induced neutral lipid accumulation which appears to be due at least in part to increased free fatty acid accumulation as evident by increased accumulation of Bodipy labeled dodecanoic acid. Additionally, 14C-acetate incorporation into total cellular lipids was increased by trans-nonachlor implicating increased de novo lipogenesis (DNL) as a potential mediator of trans-nonachlor-induced neutral lipid accumulation. Taken together, the present data indicate exposure to trans-nonachlor has a direct, pro-steatotic effect on hepatocytes to increase lipid accumulation through the combinatorial actions of extracellular free fatty acid accumulation and increased DNL.
Copyright © 2018 Elsevier Ltd. All rights reserved.

Entities:  

Keywords:  Fatty acid oxidation; Fatty acid uptake; Hepatic steatosis; Trans-nonachlor; Triglyceride; de novo lipogenesis

Mesh:

Substances:

Year:  2018        PMID: 29654899      PMCID: PMC6775778          DOI: 10.1016/j.tiv.2018.04.003

Source DB:  PubMed          Journal:  Toxicol In Vitro        ISSN: 0887-2333            Impact factor:   3.500


  45 in total

Review 1.  Nonalcoholic fatty liver disease.

Authors:  Paul Angulo
Journal:  N Engl J Med       Date:  2002-04-18       Impact factor: 91.245

Review 2.  Membrane transport of long-chain fatty acids: evidence for a facilitated process.

Authors:  N Abumrad; C Harmon; A Ibrahimi
Journal:  J Lipid Res       Date:  1998-12       Impact factor: 5.922

Review 3.  Non-alcoholic fatty liver disease and risk of cardiovascular disease.

Authors:  Amedeo Lonardo; Silvia Sookoian; Carlos J Pirola; Giovanni Targher
Journal:  Metabolism       Date:  2015-09-25       Impact factor: 8.694

4.  Sortilin facilitates VLDL-B100 secretion by insulin sensitive McArdle RH7777 cells.

Authors:  Robert P Sparks; Wayne C Guida; Mark P Sowden; Jermaine L Jenkins; Matthew L Starr; Rutilio A Fratti; Charles E Sparks; Janet D Sparks
Journal:  Biochem Biophys Res Commun       Date:  2016-08-02       Impact factor: 3.575

5.  A human hepatocellular in vitro model to investigate steatosis.

Authors:  María José Gómez-Lechón; María Teresa Donato; Alicia Martínez-Romero; Nuria Jiménez; José Vicente Castell; José-Enrique O'Connor
Journal:  Chem Biol Interact       Date:  2006-11-23       Impact factor: 5.192

Review 6.  Metabolism disrupting chemicals and metabolic disorders.

Authors:  Jerrold J Heindel; Bruce Blumberg; Mathew Cave; Ronit Machtinger; Alberto Mantovani; Michelle A Mendez; Angel Nadal; Paola Palanza; Giancarlo Panzica; Robert Sargis; Laura N Vandenberg; Frederick Vom Saal
Journal:  Reprod Toxicol       Date:  2016-10-17       Impact factor: 3.143

7.  In Vitro effect of DDE exposure on the regulation of lipid metabolism and secretion in McA-RH7777 hepatocytes: A potential role in dyslipidemia which may increase the risk of type 2 diabetes mellitus.

Authors:  Antonio B Ward; Mary B Dail; Janice E Chambers
Journal:  Toxicol In Vitro       Date:  2016-08-23       Impact factor: 3.500

8.  Polychlorinated biphenyl 153 is a diet-dependent obesogen that worsens nonalcoholic fatty liver disease in male C57BL6/J mice.

Authors:  Banrida Wahlang; K Cameron Falkner; Bonnie Gregory; Douglas Ansert; David Young; Daniel J Conklin; Aruni Bhatnagar; Craig J McClain; Matt Cave
Journal:  J Nutr Biochem       Date:  2013-04-22       Impact factor: 6.048

9.  Toxicity of trans-nonachlor to Sprague-Dawley rats in a 90-day feeding study.

Authors:  Genevieve Bondy; Ivan Curran; Josée Doucet; Cheryl Armstrong; Laurie Coady; Lynn Hierlihy; Susan Fernie; Patrick Robertson; Michael Barker
Journal:  Food Chem Toxicol       Date:  2004-06       Impact factor: 6.023

10.  Chronic consumption of farmed salmon containing persistent organic pollutants causes insulin resistance and obesity in mice.

Authors:  Mohammad Madani Ibrahim; Even Fjære; Erik-Jan Lock; Danielle Naville; Heidi Amlund; Emmanuelle Meugnier; Brigitte Le Magueresse Battistoni; Livar Frøyland; Lise Madsen; Niels Jessen; Sten Lund; Hubert Vidal; Jérôme Ruzzin
Journal:  PLoS One       Date:  2011-09-23       Impact factor: 3.240

View more
  3 in total

1.  Alterations in macrophage phagocytosis and inflammatory tone following exposure to the organochlorine compounds oxychlordane and trans-nonachlor.

Authors:  Darian Young; Aren Worrell; Erin McDevitt; Lucie Henein; George E Howell
Journal:  Toxicol In Vitro       Date:  2020-02-10       Impact factor: 3.500

2.  Effects of chlorpyrifos on non-cholinergic toxicity endpoints in immortalized and primary rat hepatocytes under normal and hepatosteatotic conditions.

Authors:  SandeepReddy Kondakala; Lucie Henein; Erin McDevitt; Matthew K Ross; George Eli Howell
Journal:  Toxicol In Vitro       Date:  2022-02-11       Impact factor: 3.500

3.  Association between organochlorine pesticides and nonalcoholic fatty liver disease in the National Health and Nutrition Examination Survey 2003-2004.

Authors:  Hyunji Sang; Kyu-Na Lee; Chang Hee Jung; Kyungdo Han; Eun Hee Koh
Journal:  Sci Rep       Date:  2022-07-08       Impact factor: 4.996

  3 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.